Last updated on March 2018

Schema Therapy for Chronic Depression


Brief description of study

To compare the efficacy of schema therapy versus active monitoring for women with chronic depression receiving psychiatric care.

Detailed Study Description

A randomized, assessor-blind, single center, superiority trial will be conducted. Participants will be referred to clinical psychologists in a private counseling office (Senzoku Stress Coping Support Office, in Japan). Eligible participants will be women with chronic depression receiving psychiatric care. Participants will receive schema therapy or active monitoring during 2 years. Primary outcome will be treatment response. A total sample size of 64 (32 in each group) would be required to provide 80% power at a 2-sided significance level of 5% to detect a risk difference of 35% (response rate: 55% for schema therapy vs. 20% for active monitoring), assuming a dropout rate of 10%.

Clinical Study Identifier: NCT03084744

Find a site near you

Start Over